Browse the corpus

REFERENCES American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, American Psychiatric Association, Washington, DC, 2000. Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry 2001; 178:101. Hamilton NL, Brantley LB, Tims FM, et al. Family Support Network for Adolescent Cannabis Users, Cannabis Youth Treatment (CYT) Series, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockville, MD 2001. Vol 3. Wells DL, Ott CA. The "new" marijuana. Ann Pharmacother 2011; 45:414. Leggett T, United Nations Office on Drugs and Crime. A review of the world cannabis situation. Bull Narc 2006; 58:1. Degenhardt L, Chiu WT, Sampson N, et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med 2008; 5:e141. Anthony, JC, Warner, LA, Kessler, RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp Clin Psychopharmacol 1994; 2:244. Degenhardt L, Chiu WT, Sampson N, et al. Epidemiological patterns of extra-medical drug use in the United States: evidence from the National Comorbidity Survey Replication, 2001-2003. Drug Alcohol Depend 2007; 90:210. Kandel D, Chen K, Warner LA, et al. Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population. Drug Alcohol Depend 1997; 44:11. von Sydow K, Lieb R, Pfister H, et al. The natural course of cannabis use, abuse and dependence over four years: a longitudinal community study of adolescents and young adults. Drug Alcohol Depend 2001; 64:347. Conway KP, Compton W, Stinson FS, Grant BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006; 67:247. Poulton R, Moffitt TE, Harrington H, et al. Persistence and perceived consequences of cannabis use and dependence among young adults: implications for policy. N Z Med J 2001; 114:544. Degenhardt L, Hall W, Lynskey M. The relationship between cannabis use and other substance use in the general population. Drug Alcohol Depend 2001; 64:319.

Poulton R, Moffitt TE, Harrington H, et al. Persistence and perceived consequences of cannabis use and dependence among young adults: implications for policy. N Z Med J 2001; 114:544. Degenhardt L, Hall W, Lynskey M. The relationship between cannabis use and other substance use in the general population. Drug Alcohol Depend 2001; 64:319. Grant BF, Pickering R. The relationship between cannabis use and DSM-IV cannabis abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse 1998; 10:255. Lynskey MT, Heath AC, Bucholz KK, et al. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA 2003; 289:427. Kaminer, Y. Adolescent substance abuse. In: The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th ed, Galanter, M, Kleber HD (Ed), American Psychiatric Publishing, Washington, DC 2008. p.527. Ross, S. The mentally ill substance abuser. In: The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th ed, Galanter, M, Kleber HD (Eds), American Psychiatric Publishing, Washington, DC 2008. p.540. Clapper JR, Mangieri RA, Piomelli D. The endocannabinoid system as a target for the treatment of cannabis dependence. Neuropharmacology 2009; 56 Suppl 1:235. Cooper ZD, Haney M. Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor. Addict Biol 2008; 13:188. Hasin DS, Keyes KM, Alderson D, et al. Cannabis withdrawal in the United States: results from NESARC. J Clin Psychiatry 2008; 69:1354. Lichtman AH, Martin BR. Cannabinoid tolerance and dependence. Handb Exp Pharmacol 2005; :691. Koob, GF. Neurobiology of addiction. In: The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th ed, Galanter, M, Kleber HD (Eds), American Psychiatric Publishing, Washington, DC 2008. p.4. Kendler KS, Karkowski LM, Neale MC, Prescott CA. Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry 2000; 57:261. Sartor, CE, Grant, JD, Bucholz, KK, et al. Common genetic contributions to alcohol and cannabis use and dependence symptomatology. Alcohol Clin Exp Res 2010; 34:1. Hopfer CJ, Lessem JM, Hartman CA, et al. A genome-wide scan for loci influencing adolescent cannabis dependence symptoms: evidence for linkage on chromosomes 3 and 9. Drug Alcohol Depend 2007; 89:34.

Sartor, CE, Grant, JD, Bucholz, KK, et al. Common genetic contributions to alcohol and cannabis use and dependence symptomatology. Alcohol Clin Exp Res 2010; 34:1. Hopfer CJ, Lessem JM, Hartman CA, et al. A genome-wide scan for loci influencing adolescent cannabis dependence symptoms: evidence for linkage on chromosomes 3 and 9. Drug Alcohol Depend 2007; 89:34. Agrawal A, Lynskey MT. Candidate genes for cannabis use disorders: findings, challenges and directions. Addiction 2009; 104:518. Lynskey MT, Heath AC, Nelson EC, et al. Genetic and environmental contributions to cannabis dependence in a national young adult twin sample. Psychol Med 2002; 32:195. Hyman SM, Sinha R. Stress-related factors in cannabis use and misuse: implications for prevention and treatment. J Subst Abuse Treat 2009; 36:400. Topic 7797 Version 8.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [1004-115.66.252.144-2A34E2F131-S244013.14]